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Background 
Young children with sickle cell disease are particularly 
susceptible to respiratory infections and septicaemia. 
Inclusion criteria 
Studies:  
Randomized controlled trials. 
Participants: 
Children with sickle cell disease, sickle cell beta 
thalassaemia, and sickle cell haemoglobin C disease.  
Intervention: 
Intervention: antibiotics given to prevent infection. 
Control: placebo, no treatment, or a different treatment 
Outcomes: 
Streptococcus pneumonia infection, antibiotic drug 
resistant organisms isolated, adverse effects. 
Results 
• Three trials involving 857 children were included; 
one conducted in Jamaica and two in the USA. One 
trial had adequate allocation concealment. 
• Twice daily oral penicillin resulted in less 
pneumococcal infections compared to no treatment 
in children aged three months to three years on one 
small trial (odds ratio 0.14, 95% confidence interval 
0.03 to 0.66; 215 participants). 
• With monthly penicillin, intention-to-treat analysis 
showed no significant difference in pneumococcal 
infections compared to a control in one small trial 
(242 children); however, all infections in the 
intervention groups occurred after injections were 
stopped at the age of three years. 
• After stopping treatment at five years, there was no 
difference detected in pneumococcal infections 
between those allocated to penicillin or placebo 
groups in one trial (400 children). Penicillin resistant 
bacteria were detected in both penicillin and placebo 
groups. 
• Adverse drug effects for oral and injected penicillin 
were rare and minor. 
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In children with sickle cell disease, does penicillin 
prevent pneumococcal infection? 
Penicillin prophylaxis can prevent pneumococcal infections in 
children under the age of five years with sickle cell disease.   
Authors’ conclusions 
Implications for practice:  
Penicillin prophylaxis can prevent pneumococcal infections in children under the age of five years with sickle cell 
disease. It appears safe and well tolerated.  
Implications for research: 
Further research into the prevalence and clinical importance of resistant organisms is needed. 
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